Condition
Digestive System Diseases clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Digestive System Diseases clinical trials that are recruiting, at sites in 17 countries (most in China (3), Spain (2), United States (2)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 17Countries
Newest Digestive System Diseases clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Signia circular stapler for left-sided colon, sigmoid, and rectal resections | — | New Haven, Connecticut and 9 other locations | Recruiting | Jan 20, 2026 |
| PF-08634404 plus chemotherapy for adults with metastatic colorectal cancer | Phase 3 | Chandler, Arizona and 371 other locations | Recruiting | Oct 30, 2025 |
| Combination treatment for ctDNA positive gastric cancer | Phase 2 | Nanjing, Jiangsu | Recruiting | Aug 9, 2022 |
| Creating 3D models of the intestine from biopsy samples | — | Rennes | Recruiting | Mar 24, 2022 |
| Combination of Anlotinib and TQB2450 for Esophageal Cancer Treatment | Phase 2 | Nanchang, Jiangxi | Recruiting | Feb 23, 2022 |
| Pooling clinical experiences of patients treated with Lutetium-177 in Spain | — | Santiago de Compostela, A Coruña and 19 other locations | Recruiting | Jul 2, 2021 |
All recruiting trials (6)
-
Signia circular stapler for left-sided colon, sigmoid, and rectal resections
This study will try the Signia circular stapler with Tri-Staple technology to see if it safely creates bowel reconnections in adults having left-sided colon, sigmoid, or rectal surgery.
-
PF-08634404 plus chemotherapy for adults with metastatic colorectal cancer
This trial will test whether adding a new drug called PF-08634404 to standard chemotherapy helps adults whose colorectal cancer has spread.
-
Combination treatment for ctDNA positive gastric cancer
This study is testing a new combination treatment for patients with a specific type of stomach cancer to see if it works better than the usual treatment.
-
Creating 3D models of the intestine from biopsy samples
This study is trying to create 3D models of the intestine from biopsy samples to help understand digestive diseases better and find new treatments.
-
Combination of Anlotinib and TQB2450 for Esophageal Cancer Treatment
This study is testing if combining two medications, Anlotinib and TQB2450, can help people with esophageal cancer stay cancer-free after surgery.
-
Pooling clinical experiences of patients treated with Lutetium-177 in Spain
This study looks at how well Lutetium-177 works and how safe it is for patients with certain types of tumors in Spain by collecting information from their medical records.
Related topics
Quick answers
How many Digestive System Diseases clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in China (3 trials), Spain (2 trials), United States (2 trials), France (2 trials), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.